Yu-jing Bai
Key Laboratory Of Vision Loss And Restoration, Beijing Key Laboratory For The Diagnosis And Treatment Of Retinal And Choroid Diseases
Beijing, 100044, China
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways.
Journal: BioMed research international
Published: July 18, 2017
Apelin induces the proliferation, migration and expression of cytoskeleton and tight junction proteins in human RPE cells via PI-3K/Akt and MAPK/Erk signaling pathways.
Journal: International journal of clinical and experimental pathology
Published: November 29, 2016
Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy.
Journal: Mediators of inflammation
Published: February 16, 2016
Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity.
Journal: Chinese medical journal
Published: September 15, 2015
Whole-exome sequencing implicates UBE3D in age-related macular degeneration in East Asian populations.
Journal: Nature communications
Published: August 01, 2014
Antiangiogenesis effects of endostatin in retinal neovascularization.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: April 03, 2013
Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions.
Journal: World journal of pediatrics : WJP
Published: December 21, 2012
KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Journal: Ophthalmic research
Published: August 29, 2012
Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 13, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026